Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Change in Receivables: 2024-2025

Historic Change in Receivables for CG Oncology (CGON) over the last 1 years, with Sep 2025 value amounting to $238,000.

  • CG Oncology's Change in Receivables rose 628.89% to $238,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $663,000, marking a year-over-year change of. This contributed to the annual value of $689,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Change in Receivables is $238,000, which was up 9.68% from $217,000 recorded in Q2 2025.
  • CG Oncology's 5-year Change in Receivables high stood at $644,000 for Q4 2024, and its period low was -$436,000 during Q1 2025.
  • For the 2-year period, CG Oncology's Change in Receivables averaged around $123,600, with its median value being $217,000 (2025).
  • Data for CG Oncology's Change in Receivables shows a peak YoY soared of 628.89% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows CG Oncology's Change in Receivables stood at $644,000 in 2024, then spiked by 628.89% to $238,000 in 2025.
  • Its Change in Receivables stands at $238,000 for Q3 2025, versus $217,000 for Q2 2025 and -$436,000 for Q1 2025.